IM Cannabis Corp.
IMCC Nasdaq· Medicinal Chemicals & Botanical Products
Last close · Nov 9, 2026
$0.63
Latest quarter · Q2 '25 results quarter ended Jun 30, 2025 · vs Q2 '24
| Line | Q2 '24 | Q2 '25 | Change (y/y) |
|---|---|---|---|
| Revenue | $10.8M | $9.2M | 15.0% |
| Net income | −$2.2M | −$0.2M | — |
| Diluted EPS | −$0.99 | −$0.06 | — |
| Operating margin | −19.5% | −2.8% | 16.7 pts |
Key numbers, fiscal 2025
Market cap
—
P/E
—
Revenue
$39.1M
Net income
−$8.1M
Free cash flow
$3.4M
Operating margin
−21.2%
IM Cannabis Corp. in 30 seconds fiscal 2025
Are sales growing?
−0.8%
No. Sales fell 0.8% last year.
Does it make a profit?
−20.7%
No. It lost money last year.
Does profit turn into cash?
8.6%
Partly. 8.6% of sales ends up as free cash.
Is debt under control?
$9.2M
Risky. It owes more than it holds in cash and has no operating profit to repay it.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
What IM Cannabis Corp. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Mar 30, 2026
- Legal name
- IM Cannabis Corp.
- CIK
- 0001792030
IM Cannabis Corp. · IMCC · stoqly.net
Results and finances
The last 5 fiscal years. Amounts in USD. Compiled by stoqly.net.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $27.2M | $41.7M | $36.2M | $39.4M | $39.1M |
| Revenue growth | 129.3% | 53.6% | −13.4% | 9.1% | −0.8% |
| Gross margin | 18.6% | 16.9% | 20.2% | 15.6% | 17.7% |
| Operating margin | −67.6% | −56.7% | −26.2% | −18.9% | −21.2% |
| Net income | −$14.2M | −$145M | −$7.0M | −$7.7M | −$8.1M |
| Net margin | −52.2% | −347.6% | −19.5% | −19.6% | −20.7% |
| Diluted EPS | −$5.34 | −$124.35 | −$3.30 | −$3.29 | — |
| Cash | |||||
| Cash from operations | −$27.4M | −$9.7M | −$6.0M | −$0.8M | $3.4M |
| Capital expenditure | $3.7M | $1.2M | $0.4M | $0.1M | $0.0M |
| Free cash flow | −$31.1M | −$10.9M | −$6.4M | −$0.9M | $3.4M |
| FCF margin | −114.4% | −26.1% | −17.7% | −2.3% | 8.6% |
| Share count change | −84.5% | 25.2% | 71.3% | — | — |
| Debt and strength | |||||
| Cash and short-term investments | $10.9M | $1.8M | $1.4M | $0.6M | $2.0M |
| Debt incl. finance leases | $9.9M | $7.1M | $9.4M | $10.8M | $11.2M |
| Shareholders' equity | $158M | $16.7M | $10.9M | $3.6M | −$2.7M |
| Current ratio | 1.6x | 1.0x | 0.7x | 0.7x | 0.7x |
| Interest coverage | −34.2x | −15.6x | −3.5x | −2.1x | −3.3x |
| Returns and quality | |||||
| Return on capital | −9.2% | −84.8% | −39.4% | −42.5% | −101.7% |
| Return on equity | −17.0% | −165.7% | −50.9% | −106.1% | −1,760.5% |
| Return on tangible equity | −36.7% | −3,951.7% | — | — | — |
| Piotroski F-score | 2 | 2 | 4 | 2 | 4 |
| Altman Z'' | 2.1 | −15.9 | −19.1 | −25.2 | −32.6 |
Insider trades 12 months
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
IM Cannabis Corp. · IMCC · stoqly.net
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Compiled and analysed by stoqly.net from SEC EDGAR XBRL filings (CIK 0001792030). Latest version: stoqly.net/companies/imcc. Data updated November 9, 2026. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.